Preserving Muscle Mass

If you’ve spent any time searching “GLP-1 muscle loss” online, you’ve probably seen the headlines. Muscle wasting. Dangerous loss of lean tissue. Metabolic damage. The narrative makes it sound like these medications strip the muscle off your bones while the fat disappears.

That narrative is wrong. Not completely — there’s a real concern buried under the panic — but the framing is so distorted that most people walk away more scared than they need to be.

Here’s what this page will do: walk you through the actual clinical data on what happens to muscle during GLP-1 weight loss, put those numbers in context against every other form of weight loss, and then show you what works to protect and even build muscle while you’re losing weight. Because the solution isn’t just real — it’s well-proven and entirely within your control.


What the Headlines Get Wrong

GLP-1 medications don't cause unusual muscle loss. They follow the same pattern as every other form of weight loss.

Roughly 75% of weight lost is fat, 25% is lean mass. That ratio holds for dieting, exercise-based programs, and GLP-1 medications alike. It's called "the 25% rule" — and it's remarkably consistent regardless of how the weight comes off.[1][2]

Where GLP-1s actually compare favorably is against bariatric surgery. A 2025 JAMA study found surgery patients lost 11.7% of their fat-free mass at 24 months — more than three times the 3.3% seen with GLP-1 medications.[3]

So when someone tells you GLP-1s cause alarming muscle loss, the appropriate follow-up question is: compared to what? Because the answer is “the same as dieting, and far less than surgery.”


The Actual Numbers

The data from major clinical trials tells a more nuanced story than “GLP-1s destroy muscle.” Let’s go through it.

TrialParticipantsKey Finding
STEP 1 (Semaglutide)140 scannedLean mass ↓9.7%, but lean-to-total ratio ↑3.0 points. Bodies were proportionally leaner.
SURMOUNT-1 (Tirzepatide)160 scannedSame 75/25 ratio across all age groups — older adults lost no more muscle than younger ones.
SEMALEAN (2025)115 patientsLean mass stabilized after 7 months. Grip strength ↑4.5 kg. Sarcopenic obesity dropped 49% → 33%.

STEP 1 found that fat mass dropped 19.3% while lean mass dropped 9.7%. That sounds concerning until you look at the ratio: lean mass as a proportion of total body weight actually increased by 3.0 percentage points.[4] People had less muscle in absolute terms, but their bodies were proportionally more muscle and less fat than before treatment.

SURMOUNT-1 found the same 75/25 fat-to-lean ratio held across every age group: under 50, 50 to 64, and 65 and older.[2] Older adults weren’t losing disproportionately more muscle than younger ones.

SEMALEAN found that lean mass stopped declining even as patients continued treatment — and grip strength actually improved.[5] People started the study with weak, under-muscled, fat-heavy bodies and ended up with stronger, better-proportioned ones.

Perhaps the most important framing comes from a Circulation review by Neeland and colleagues, who concluded that the skeletal muscle changes seen in GLP-1 trials “appear to be adaptive” — meaning the reduction in muscle is proportionate to the reduction in body size, not a pathological breakdown of tissue.[6] A 300-pound body needs more muscle to move through the world than a 220-pound body. When the body shrinks, some muscle reduction isn’t loss — it’s recalibration.

Did You Know?

A 2025 JAMA study found that bariatric surgery patients lost 11.7% of their fat-free mass at 24 months — more than three times the 3.3% seen with GLP-1 medications over the same period. GLP-1s consistently show less lean mass loss than the most common surgical alternative, but that comparison rarely makes the headlines. Source: Koliaki et al., JAMA Network Open, 2025


Muscle Quality vs. Muscle Quantity

Here’s a piece of the puzzle most articles miss entirely: it’s not just about how much muscle you have. It’s about what kind of muscle you have.

The SURPASS-3 trial used MRI scans to look at what was happening inside the muscle, not just how big it was. They found that tirzepatide reduced muscle fat infiltration — the amount of fat marbled through the muscle tissue — by 0.36 percentage points.[7] The muscles got smaller, yes. But they also got healthier. Less fat-marbled, more functional per unit of tissue.

Think of it like this: a fatty, marbled steak has more mass than a lean cut. But the lean cut is higher-quality meat. Your muscles after GLP-1 treatment may weigh less, but they’re working better pound for pound.

There’s a cellular-level finding that backs this up too. A 2025 study published in Obesity found that semaglutide improved mitochondrial efficiency — the energy-producing machinery inside your cells. Mitochondria in muscle cells were generating energy more effectively after treatment.[8] Smaller muscles, but muscles that work better at the cellular level.

Less fat marbling — SURPASS-3 MRI scans showed tirzepatide reduced fat infiltration within the muscle tissue itself.[7]

Better cellular energy — Semaglutide improved mitochondrial efficiency in muscle cells, meaning better energy production per unit of tissue.[8]

None of this means muscle loss doesn’t matter. It does. But the full picture is more encouraging than “your muscles are shrinking” — because the muscles you’re keeping are higher quality, stronger, and more metabolically efficient.


The Three-Part Solution: Resistance Training, Protein, and Consistency

The muscle loss concern is real. And the solution is clear, well-studied, and something you can start today.

Resistance Training

The signal that tells your body "keep the muscle." Without it, your body has no reason to maintain tissue it doesn't think you're using.

Adequate Protein

The raw materials. 1.2-1.6 g/kg/day, spread across meals at 20-40g each. Without it, the muscle-building signal has nothing to work with.

Remove any one of those three (plus consistency) and the results drop off. Together, they’re remarkably effective.

The Proof

The most striking evidence comes from a 2025 case series by Tinsley and colleagues, tracking three patients on semaglutide or tirzepatide who combined their medication with resistance training 3-5 times per week and adequate protein intake. The results were extraordinary:[9]

  • Patient 1: Lost 33.0% of body weight. Only 8.7% of the weight lost was lean mass — compared to the typical 25-40%. Lean mass declined just 6.9%.
  • Patient 2: Lost 26.8% of body weight. Gained 2.5% lean mass.
  • Patient 3: Lost 13.2% of body weight. Gained 5.8% lean mass.

Two out of three patients didn’t just preserve muscle — they built it. While losing massive amounts of weight. On a medication that’s supposed to eat muscle. That’s the power of resistance training plus protein.

A larger study of approximately 200 patients reported by Medscape found that providing resistance training education and protein guidance alongside GLP-1 treatment resulted in roughly 13% total body weight loss but only about 3% muscle loss.[10] Compare that to the BELIEVE trial, where semaglutide alone — no exercise intervention, no protein guidance — produced 15.7% weight loss with 28.2% of the loss coming from lean mass.[11] The difference between “doing the basics” and “not doing the basics” is that stark.

Why It Works

When you lift something heavy — or do a bodyweight exercise that challenges your muscles — your body activates what’s called the mTOR pathway. Think of mTOR as a switch: when it’s turned on, it tells your muscle cells to build and repair. When it’s off, your body defaults to breaking muscle down for energy, especially during weight loss.[12]

Resistance training flips that switch. And protein provides the building blocks — the amino acids — your muscles need to actually do the rebuilding. Without the signal (resistance training), protein just gets used for energy. Without the building blocks (protein), the signal doesn’t have materials to work with. You need both.

A 2025 international expert consensus using a modified Delphi process — where 80% of experts had to agree for a recommendation to stand — put it plainly: “A high protein intake alone does not increase muscle mass. For preservation of lean body mass, an exercise training program based on resistance training at moderate-to-high intensity is advised.”[12] Protein alone isn’t enough. Exercise alone isn’t enough. The combination is what works.

How Much Protein

The 2025 Joint Advisory from the American Society for Metabolic and Bariatric Surgery and the Obesity Medicine Association recommends 1.2 to 1.6 grams of protein per kilogram of body weight per day during active weight loss on GLP-1 medications.[13] For someone who weighs 200 pounds (91 kg), that’s roughly 109 to 145 grams of protein daily.

To make those grams count for muscle, research suggests spreading protein across meals — 20 to 40 grams per meal — to maximize what’s called muscle protein synthesis, the process by which your body actually turns dietary protein into muscle tissue.[12] Eating 100 grams of protein in one sitting isn’t as effective as spreading it across four meals of 25 grams each.

From Brandon's Experience:

I’ll be honest — the muscle loss headlines freaked me out early on. I was losing weight fast and I could feel things getting looser in ways that didn’t feel like just fat loss. That’s when I got serious about resistance training and protein. I’m not going to pretend I was some disciplined gym person before this. I wasn’t. But once I understood that the solution was straightforward — pick things up, put them down, eat enough protein — it stopped feeling like an impossible problem and started feeling like a project. And the data backs it up: you have way more control over this than the scary articles suggest.


A Note for Older Adults

Muscle loss compounds with age. After 30, most people lose about 3-8% of muscle mass per decade — a process called sarcopenia — and it accelerates after 60.[14] Adding GLP-1-driven weight loss on top of age-related muscle decline is a legitimate concern, and it deserves a direct answer.

The answer, thankfully, is encouraging. The SURMOUNT-1 trial data showed that the 75/25 fat-to-lean ratio held even in participants aged 65 and older — older adults weren’t losing disproportionately more muscle than younger ones.[2] And a 2025 analysis presented at ENDO found that higher protein intake was specifically associated with less muscle loss in older patients on semaglutide.[14]

Resistance training isn’t just helpful for older adults on GLP-1s — it’s considered first-line treatment for sarcopenia by every major geriatric and exercise medicine organization.[12] Balance training matters too, since preserving muscle also means reducing fall risk.

Protein targets for older adults during GLP-1 treatment land at the higher end of the range — closer to 1.4-1.6 g/kg/day — because aging muscles are less efficient at converting dietary protein into new muscle tissue.[13] The machinery still works. It just needs more raw material.


The Bottom Line

The muscle loss conversation around GLP-1 medications has been badly distorted by headlines optimized for clicks rather than clarity. The reality: GLP-1s follow the same lean mass loss pattern as every other form of significant weight loss — and do considerably better than bariatric surgery. The muscle that remains after treatment is leaner, less fat-marbled, and more efficient.

But here’s the part that matters most: you’re not stuck with whatever your body defaults to. Resistance training plus adequate protein doesn’t just slow muscle loss — in some cases, it reverses it entirely. People are gaining muscle while losing 25%+ of their body weight on these medications. That’s not a theoretical possibility. It’s published data.

The next page in this section covers strength training fundamentals — how to get started with resistance training even if you’ve never touched a weight. Because the best time to start protecting your muscle was when you started the medication. The second-best time is now.


Sources:

  1. Heymsfield SB, et al. “Weight loss composition is one-fourth fat-free mass: a critical review and critique of this widely cited rule.” Obesity Reviews, 2014.
  2. Jastreboff AM, et al. “Body composition and cardiometabolic effects of tirzepatide in adults with obesity.” Diabetes, Obesity and Metabolism, 2025.
  3. Koliaki C, et al. “Lean body mass changes following bariatric surgery vs. GLP-1 receptor agonists.” JAMA Network Open, 2025.
  4. Wilding JPH, et al. “Body composition effects of once-weekly semaglutide 2.4 mg (STEP 1 DEXA substudy).” Diabetes, Obesity and Metabolism, 2021.
  5. Bates JT, et al. “SEMALEAN: Body composition and strength outcomes in semaglutide-treated patients.” Diabetes, Obesity and Metabolism, 2025.
  6. Neeland IJ, et al. “Effects of GLP-1 receptor agonists on body composition: adaptive skeletal muscle changes.” Diabetes, Obesity and Metabolism, 2025.
  7. Gastaldelli A, et al. “Tirzepatide reduces intramuscular fat deposition (SURPASS-3 MRI substudy).” Diabetes Care, 2025.
  8. Choi DH, et al. “Semaglutide improves mitochondrial OXPHOS efficiency in skeletal muscle.” Obesity, 2025.
  9. Tinsley GM, et al. “Resistance training preserves lean mass during GLP-1 receptor agonist treatment: a case series.” Obesity Pillars, 2025.
  10. Medscape. “Resistance Training, Protein May Lower GLP-1 RA Muscle Loss.” 2025.
  11. American Diabetes Association. “New GLP-1 Therapies Enhance Quality of Weight Loss, Improving Muscle Outcomes (BELIEVE trial).” 2025.
  12. International Expert Panel. “Nutritional and lifestyle supportive care recommendations for management of obesity with GLP-1-based therapies: An expert consensus statement using a modified Delphi approach.” Obesity Pillars, 2025.
  13. ASMBS/OMA Joint Advisory. “Protein and exercise recommendations during GLP-1 receptor agonist treatment.” Surgery for Obesity and Related Diseases, 2025.
  14. Haines MS, et al. “Risk factors for lean mass loss during semaglutide treatment.” Presented at ENDO 2025, Endocrine Society, 2025.

Want to Start Tracking Your Progress?

Printable templates designed for people on GLP-1 medications — side effect trackers, progress logs, meal planners, and more.

View Templates